Webcast CME

CME Webcasts

CME Webcasts

Inflammatory Bowel Disease:
Steering the Disease Course of IBD

 

Print this Content

How to Obtain AMA PRA Category 1 Credit

  1. Watch the webcast.
  2. Complete the CME posttest (each question must be answered correctly).
  3. Login to your account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.

Technical Requirements



Release Date:   July 17, 2013
Expiration Date:   July 17, 2015

Estimated Time of Completion:   2 hours

Description

The Inflammatory Bowel Disease: Steering the Disease Course of IBD Webcast was developed from the Cleveland Clinic Digestive Disease Institute’s Inflammatory Bowel Disease: Steering the Disease Course of IBD satellite symposium, held during Digestive Disease Week.

Designed for health care practitioners who treat inflammatory bowel disease, the webcast uses a case-based interdisciplinary approach to address the full range of treatment options and associated advantages and disadvantages to minimize risk and improve patient outcomes. Featuring colorectal surgeons and gastroenterology physicians, the webcast focuses on in-depth clinical perspectives focusing on the surgical and medical therapy for inflammatory bowel disease.

Learning Objectives

  1. Describe efficacy, safety, indications, and patient selection criteria (individualized therapy) for biologic use in patients with Clostridium difficile or ulcerative colitis.
  2. Appraise the impact of biologic use on infection risks, including Clostridium difficile infection.
  3. Summarize the most up-to-date information on advances in medical and surgical treatment for complex CD and describe their impact on clinical practice, including combined vs monobiological therapy, step-up vs top-down therapy, mucosal healing, and bowel preserving stricturoplasty.
  4. Present pros and cons of aggressive medical therapy and surgery in patients with Clostridium difficile or ulcerative colitis and apply the knowledge to clinical practice.
  5. Create a management strategy to minimize medical and surgical adverse sequelae of the selected therapy.
  6. Identify strategies for building alliances between gastroenterologists and colorectal surgeons.

Target Audience

This webcast series is directed to general internists, gastroenterologists, general surgeons, colorectal surgeons, trainees in gastroenterology and colorectal surgery, nurses, nurse practitioners, and other associated health care professionals who treat inflammatory bowel disease.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Bo Shen, MD
Professor of Medicine
Department of Gastroenterology
Digestive Disease Institute
Cleveland Clinic
Cleveland, OH

Feza H. Remzi, MD, FACS, FASCRS, FTSS (Honorary)
Chairman, Department of Colorectal Surgery
Ed and Joey Story Chair in Colorectal Surgery
Digestive Disease Institute
Director, Center for International Medical Education
Education Institute
Cleveland Clinic
Cleveland, OH

Faculty

Jean Ashburn, MD
Staff Colorectal Surgeon
Department of Colorectal Surgery
Digestive Disease Institute
Cleveland Clinic
Cleveland, OH

Gary R. Lichtenstein, MD
Professor of Medicine
Director, Center for Inflammatory
Bowel Disease
University of Pennsylvania
Philadelphia, PA

Lori Mahajan, MD
Department of Pediatric Gastroenterology
Pediatric Institute
Cleveland Clinic
Cleveland, OH

David T. Rubin, MD
Professor of Medicine
CoDirector, Inflammatory Bowel Disease Center
The University of Chicago Medicine
Chicago, IL

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentations, could be perceived as a potential conflict of interest:


Gary R. Lichtenstein, MD

Abbott Laboratories; Elan Pharmaceuticals, Inc.;
Hospira; Meda Pharmaceuticals; Millennium;
Ono Pharmaceuticals; Pfizer, Inc.; Santarus, Inc.;
Schering Plough Corporation; Takeda; Wyeth
Consulting
  Alaven; Centocor, Inc.; Ferring Pharmaceuticals;
Procter & Gamble; Prometheus;
Salix Pharmaceuticals, Inc.; Shire USA; UCB, Inc.;
Warner Chilcott
Consulting, Research

Bristol Myers Research
 
David T. Rubin, MD

Abbvie; Janssen; UCB, Inc.; Warner Chilcott
Consulting
  Santarus, Inc. Consulting, Teaching and Speaking
 
Bo Shen, MD

Abbvie; Aptalis Teaching and Speaking

The following faculty have indicated that they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Jean Ashburn, MD
Lori Mahajan, MD
Feza H. Remzi, MD


The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for support of this activity from:

AbbVie, Inc.
Aptalis Pharma US, Inc.
Covidien
Elan Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc.

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the Digestive Disease Institute.

 
Bookmark this Chapter
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195